Abstract
Existing data have shown a major effect of glutathione S-transferase (GST) single-nucleotide polymorphisms on activities of detoxification-related enzymes, and it is the functional importance that leads to extensive research on the association of GST polymorphisms with the risk of developing brain tumor. Previously reported associations, nevertheless, remain inconsistent. This study aimed to reevaluate the association with new information from recent research articles. We weekly searched multiple databases, aiming to cover all studies looking at the associations being examined in this work. Eligibility of studies was evaluated based on predesigned inclusion criteria. To assess the association of GST polymorphisms with brain tumor risk, we calculated genotypic ORs by comparing the number of genotypes between cases and controls. We also detected interstudy heterogeneity, publication bias, and single studies’ influence. A total of 13 research articles were identified through databases and hand search. We found significantly elevated risk of brain tumor associated with GSTT1 null status in individuals of European ethnicity (OR 1.46, 95 % CI 1.12–1.92). In the analysis of GSTP1 I105V, we observed that Val/Val genotype compared to the Ile/Ile genotype was more prone to a reduced brain tumor risk (OR 0.77, 95 % CI 0.64–0.93). Such major effects were similarly seen for GSTP1 A114V (OR 1.14, 95 % CI 1.01–1.29 for Val/Val + Ala/Val vs. Ala/Ala). When data were limited to glioma, we found a significant elevation associated with the combination of Val/Val and Ala/Val genotypes (OR 1.18, 95 % CI 1.01–1.37). However, no clear association was detected between other polymorphisms investigated and glioma. These statistical data suggest that some of the polymorphisms at GST loci are possibly associated with the genetic risk of brain tumor.
Similar content being viewed by others
References
Gu J, Liu Y, Kyritsis AP, Bondy ML (2009) Molecular epidemiology of primary brain tumors. Neurotherapeutics 6(3):427–435
Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2(9):494–503, quiz 491 p following 516
Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4(4):278–299
Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113(7 Suppl):1953–1968
Ostrom QT, Barnholtz-Sloan JS (2011) Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep 11(3):329–335
Bondy M, Wiencke J, Wrensch M, Kyritsis AP (1994) Genetics of primary brain tumors: a review. J Neurooncol 18(1):69–81
Stefanaki K, Alexiou GA, Stefanaki C, Prodromou N (2012) Tumors of central and peripheral nervous system associated with inherited genetic syndromes. Pediatr Neurosurg 48(5):271–285
Honma HN, De Capitani EM, Perroud MW Jr, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L (2008) Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 61(2):152–162
Hlavata I, Vrana D, Smerhovsky Z, Pardini B, Naccarati A, Vodicka P, Novotny J, Mohelnikova-Duchonova B, Soucek P (2010) Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol Rep 24(5):1347–1353
Garcia-Gonzalez MA, Quintero E, Bujanda L, Nicolas D, Benito R, Strunk M, Santolaria S, Sopena F, Badia M, Hijona E, Perez-Aisa MA, Mendez-Sanchez IM, Thomson C, Carrera P, Piazuelo E, Jimenez P, Espinel J, Campo R, Manzano M, Geijo F, Pellise M, Gonzalez-Huix F, Espinos J, Tito L, Zaballa M, Pazo R, Lanas A (2012) Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis 27(6):771–777
Oliveira C, Lourenco GJ, Sagarra RA, Derchain SF, Segalla JG, Lima CS (2012) Polymorphisms of glutathione S-transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) genes and epithelial ovarian cancer risk. Dis Markers 33(3):155–159
Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30(6):445–600
Hayes JD, Strange RC (1995) Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 22(3):193–207
Cammer W, Tansey F, Abramovitz M, Ishigaki S, Listowsky I (1989) Differential localization of glutathione-S-transferase Yp and Yb subunits in oligodendrocytes and astrocytes of rat brain. J Neurochem 52(3):876–883
Campbell E, Takahashi Y, Abramovitz M, Peretz M, Listowsky I (1990) A distinct human testis and brain mu-class glutathione S-transferase. Molecular cloning and characterization of a form present even in individuals lacking hepatic type mu isoenzymes. J Biol Chem 265(16):9188–9193
Strange RC, Fryer AA, Matharoo B, Zhao L, Broome J, Campbell DA, Jones P, Pastor IC, Singh RV (1992) The human glutathione S-transferases: comparison of isoenzyme expression in normal and astrocytoma brain. Biochim Biophys Acta 1139(3):222–228
Elexpuru-Camiruaga J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J, Broome J, Jones P, Inskip A, Alldersea J et al (1995) Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 55(19):4237–4239
Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM, Wei Q, Bondy ML (1998) Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev 7(6):553–555
De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA (2003) Genetic polymorphisms in GSTM1, −P1, −T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 12(1):14–22
Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, Rannug A, Auvinen A, Christensen HC, Henriksson R, Johansen C, Lindholm C, Malmer B, Salminen T, Schoemaker MJ, Swerdlow AJ, Feychting M (2007) An international case–control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev 16(3):559–565
Ezer R, Alonso M, Pereira E, Kim M, Allen JC, Miller DC, Newcomb EW (2002) Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neurooncol 59(2):123–134
Pinarbasi H, Silig Y, Gurelik M (2005) Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genet Cytogenet 156(2):144–149
Harris MJ, Coggan M, Langton L, Wilson SR, Board PG (1998) Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 8(1):27–31
Ishimoto TM, Ali-Osman F (2002) Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics 12(7):543–553
Lai R, Crevier L, Thabane L (2005) Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14(7):1784–1790
Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Harbord RM, Egger M, Sterne JA (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25(20):3443–3457
Sima XT, Zhong WY, Liu JG, You C (2012) Lack of association between GSTM1 and GSTT1 polymorphisms and brain tumour risk. Asian Pac J Cancer Prev 13(1):325–328
Yao L, Ji G, Gu A, Zhao P, Liu N (2012) An updated pooled analysis of glutathione S-transferase genotype polymorphisms and risk of adult gliomas. Asian Pac J Cancer Prev 13(1):157–163
Fan Z, Wu Y, Shen J, Zhan R (2013) Glutathione S-transferase M1, T1, and P1 polymorphisms and risk of glioma: a meta-analysis. Mol Biol Rep 40(2):1641–1650
Xie P, Liang Y, Liang G, Liu B (2014) Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis. Tumour Biol 35(1):493–499
Li G, Jin TB, Wei XB, He SM, Liang HJ, Yang HX, Cui Y, Chen C, Cai LB, Gao GD (2012) Selected polymorphisms of GSTP1 and TERT were associated with glioma risk in Han Chinese. Cancer Epidemiol 36(6):525–527
Salnikova LE, Belopolskaya OB, Zelinskaya NI, Rubanovich AV (2013) The potential effect of gender in CYP1A1 and GSTM1 genotype-specific associations with pediatric brain tumor. Tumour Biol 34(5):2709–2719
Kilburn L, Okcu MF, Wang T, Cao Y, Renfro-Spelman A, Aldape KD, Gilbert MR, Bondy M (2010) Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients. Cancer 116(9):2242–2249
Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G, Adatto P, Hess K, Ali-Osman F, Groves M, Yung AW, Levin VA, Wei Q, Bondy M (2004) Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 10(8):2618–2625
Brackett J, Krull KR, Scheurer ME, Liu W, Srivastava DK, Stovall M, Merchant TE, Packer RJ, Robison LL, Okcu MF (2012) Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro Oncol 14(8):1018–1025
Barahmani N, Carpentieri S, Li XN, Wang T, Cao Y, Howe L, Kilburn L, Chintagumpala M, Lau C, Okcu MF (2009) Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro Oncol 11(3):292–300
Wiencke JK, Wrensch MR, Miike R, Zuo Z, Kelsey KT (1997) Population-based study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. Carcinogenesis 18(7):1431–1433
Hand PA, Inskip A, Gilford J, Alldersea J, Elexpuru-Camiruaga J, Hayes JD, Jones PW, Strange RC, Fryer AA (1996) Allelism at the glutathione S-transferase GSTM3 locus: interactions with GSTM1 and GSTT1 as risk factors for astrocytoma. Carcinogenesis 17(9):1919–1922
Kondrat'eva TV, Imianitov EN, Togo AV, Zaitseva OA, Iatsuk OS, Bersnev VP, Khanson KP (1999) L-myc and GSTM1 polymorphism in cerebral glioma. Vopr Onkol 45(5):523–527
Butler MA, Ruder AM, Daly AK, Waters MA, Carreon T, Schulte PA (2003) Polymorphisms in GSTM1, GSTT1, GSTP1 and NAT2 and susceptibility to primary intracranial brain gliomas. Proc Am Assoc Cancer Res 44(44):128
Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Aldape K, McMillan A, Wiencke JK (2004) Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev 13(3):461–467
Coutinho P, Sandim V, Oliveira JA, Alves G, Hatagima A (2010) Lack of association between glutathione S-transferase polymorphisms and primary glioma in a case–control study in Rio de Janeiro. Genet Mol Res 9(1):539–544
Silva MM, Da Fonseca CO, Moura-Neto R, Carvalho JF, Quirico-Santos T, Carvalho MG (2013) Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy. Genet Mol Res 12(2):1621–1630
Custodio AC, Almeida LO, Pinto GR, Santos MJ, Almeida JR, Clara CA, Rey JA, Casartelli C (2010) GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res 9(4):2328–2334
Dong YS, Hou WG, Li XL, Jin TB, Li Y, Feng DY, Liu DB, Gao GD, Yin ZM, Qin HZ (2014) Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population. Tumour Biol 35(5):4937–4941
Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61(3):154–166
Norppa H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149(1–3):309–334
Jurkovic Mlakar S, Prezelj J, Osredkar J, Marc J (2012) BMD values and GSTM3 gene polymorphisms in combination with GSTT1/GSTM1 genes: a genetic association study in Slovenian elderly. Gerontology 58(3):238–248
Saadat I, Saadat M (2010) Influence of genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) on hematological parameters. Mol Biol Rep 37(1):249–253
Strange RC, Spiteri MA, Ramachandran S, Fryer AA (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482(1–2):21–26
Ginsberg G, Smolenski S, Hattis D, Guyton KZ, Johns DO, Sonawane B (2009) Genetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev 12(5–6):389–439
Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167(7):759–774
Chen B, Zhou Y, Yang P, Wu XT (2010) Glutathione S-transferase M1 gene polymorphism and gastric cancer risk: an updated analysis. Arch Med Res 41(7):558–566
Conflict of Interest
The authors have declared that no competing interests exist.
Author information
Authors and Affiliations
Corresponding author
Additional information
Peiliang Geng and Jianjun Li contributed equally to this work.
Rights and permissions
About this article
Cite this article
Geng, P., Li, J., Wang, N. et al. Genetic Contribution of Polymorphisms in Glutathione S-Transferases to Brain Tumor Risk. Mol Neurobiol 53, 1730–1740 (2016). https://doi.org/10.1007/s12035-015-9097-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9097-2